We are live on ! Find out more
NAUT icon

Nautilus Biotechnolgy

44 hedge funds and large institutions have $165M invested in Nautilus Biotechnolgy in 2021 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 5 increasing their positions, 12 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

2% more funds holding

Funds holding: 43 → 44 (+1)

6% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 16

1% less call options, than puts

Call options by funds: $393K | Put options by funds: $395K

7.88% less ownership

Funds ownership: 85.54% → 77.66% (-7.9%)

25% less capital inflows, than outflows

Capital inflows: $34.2M | Capital outflows: $45.4M

58% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 12

Holders
44
Holders Change
+1
Holders Change %
+2.33%
% of All Funds
0.77%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
17
Increased
5
Reduced
12
Closed
16
Calls
$393​K
Puts
$395​K
Net Calls
-⁠$2​K
Net Calls Change
-⁠$2​K

NAUT Hedge Fund Activity: Q1 2021 in Review

44 of the 5,715 institutional investors tracked by Wall St. Rank reported a position in Nautilus Biotechnolgy (NAUT) for Q1 2021, worth a combined $165M — up 15% from $143M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new NAUT positions and 16 closed out — a net gain of 1 holder — while 5 added to existing stakes and 12 trimmed.

The largest buyer was Alpha Wave Global, opening a new position worth an estimated $8.44M. The largest seller was Sage Rock Capital Management, exiting entirely with an estimated $5.81M sold.

  • 44 institutional investors held Nautilus Biotechnolgy (NAUT) as of Q1 2021, up from 43 in Q4 2020.
  • Funds reported $165M of Nautilus Biotechnolgy stock for Q1 2021, up 15% quarter-over-quarter.
  • 17 funds opened new Nautilus Biotechnolgy positions in Q1 2021 and 16 closed out, a net change of +1 holder.
  • The largest Nautilus Biotechnolgy buyer in Q1 2021 was Alpha Wave Global, an estimated $8.44M added.
  • The largest Nautilus Biotechnolgy seller in Q1 2021 was Sage Rock Capital Management, an estimated $5.81M sold.

Based on aggregated 13F filings for Q1 2021.